CD274 and hepatocellular carcinoma: To test whether sorafenib‐resistant HCC growth is also inhibited, sorafenib‐resistant HCC were orthotopically implanted into humanized NSG‐SGM3 mice and tested for ATRA+HDACi+anti‐PD‐L1 treatment.